BCAL Diagnostics Ltd BDX.AX
AUD0.09
Last Updated: Oct 09, 12:00 AM·ASX
Pricing for AU stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is BCAL Diagnostics Ltd Stock Halal?
Shariah Compliance Analysis of BDX.AX Stock
Australia Health Care Nano Cap No. As of October 2026, BCAL Diagnostics Ltd (BDX.AX) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. BCAL Diagnostics Ltd does not pass Musaffa's business and financial screening criteria.
BCAL Diagnostics Ltd. is a biotechnology company, which develops screening tests for the early diagnosis and monitoring of breast cancer. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-07-21. The firm develops early, non-invasive blood test-based diagnostic technologies designed to complement mammograms and improve breast cancer screening outcomes. Its commercial laboratory, equipped with Liquid Chromatography Mass Spectrometry (LCMS) technology, is focused on scientific innovation and clinical service delivery, supporting both ongoing research and the commercial rollout of our diagnostic test. The firm develops a blood test for breast cancer screening and diagnosis. The assay measures a panel of lipids in blood plasma using Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). Its lipid measurements are converted to a test score using a proprietary diagnostic algorithm. The company offers BREASTEST plus, which is a blood test designed to be used alongside a mammogram in breast cancer screening. The company provides information for women with dense breasts to help rule out the presence of breast cancer.
BDX.AX Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, BCAL Diagnostics Ltd is classified as not halal.
NOT HALALBCAL Diagnostics Ltd (BDX.AX) Chart
Fetching Price Chart...
Financial Metrics & Statements of BCAL Diagnostics Ltd (BDX.AX)
FAQ's for BCAL Diagnostics Ltd (BDX.AX)
- As of October 2026, BCAL Diagnostics Ltd BDX.AX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BCAL Diagnostics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in BCAL Diagnostics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of BCAL Diagnostics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of BCAL Diagnostics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of BCAL Diagnostics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for BCAL Diagnostics Ltd (BDX.AX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
